MEDICATION FOR IMMUNITY INDUCTION AND METHOD OF MALIGNANT TUMOUR IDENTIFICATION Russian patent published in 2014 - IPC A61K39/00 

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention discloses an immune-inducing medication, which includes as an effective ingredient(s) at least one polypeptide, selected from the following polypeptides, where polypeptide(s) possess immune-inducing activity/activities, or as an effective ingredient(s) a recombinant vector(s), which include polynucleotide(s), coding polypeptide(s) and capable of polypeptide(s) expression in vivo, can be used for treatment and/or prevention of malignant tumour: (a) polypeptide, consisting in fact of not fewer than 7 successive amino acids in any of the amino acid sequences with odd numbers SEQ ID NO: 3-95, given in the list of sequences; (b) polypeptide, possessing not less than 90% identity of sequence with the said polypeptide (a) and consisting in fact of not fewer than 7 amino acids; and (c) polypeptide, including the said polypeptide (a) or (b) as its partial sequence.

EFFECT: invention is efficient in treatment, prevention and identification of cancer in a live organism by measuring the level of antibodies in a sample, as the said polypeptide(s) interact(s) with antibodies, specifically present in serum of the patient with malignant tumour.

12 cl, 5 dwg, 7 ex